Federal contract award
75A50123C00042
ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $45.9M |
| Current contract value | $45.9M |
| Potential contract value / ceiling | $70.1M |
| Start date | Sep 29, 2023 |
| Current end date | Sep 28, 2028 |
| Potential end date | Sep 28, 2028 |
| Latest award activity | Sep 3, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 3, 2026 | P00007 | $9.8M | THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO: (1) EXERCISE AND FUND CLIN 0015/OPTION 13 AND CLIN 0017/OPTION 15; (2) PROVIDE SUPPLEMENTAL FUNDING FOR CLIN 0016/OPTION 14; (3) REVISE ARTICLE IV, MANAGEMENT OF THE PROGRAM, TO UPDATE THE RECIPIENT/G |
| May 27, 2026 | P00006 | $0 | NO COST ADMINISTRATIVE MOD TO REVISE SECTION - ARTICLE VI: COST PLUS FIXED FEE, WITH UPDATED DCMA INDIRECT RATES. |
| Dec 17, 2025 | P00005 | $0 | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING:: NO COST MODIFICATION TO REVISE BUDGET AND FUNDING AMOUNTS FOR CLIN 0009 AND CLIN 0010. |
| Sep 25, 2025 | P00004 | $1.3M | EXERCISE CLIN0016/OPTION 14 AND REVISE THE STATEMENT OF WORK. |
| Nov 6, 2024 | P00003 | $0 | THE PURPOSE OF THIS NO COST MOD IS TO REVISE ARTICLE IV: MANAGEMENT OF THE PROGRAM, A. RECIPIENT/GOVERNMENT JOINT OVERSIGHT COMMITTEE, NON-VOTING ATTENDEES. |
| Sep 26, 2024 | P00002 | $8.1M | ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC |
| Jan 25, 2024 | P00001 | $0 | ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC |
| Sep 29, 2023 | 0 | $26.7M | ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC |
Estimated positioning window
Sep 28, 2027 – Mar 28, 2028
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2028-09-28 (697 days from calculation)
- +25 points
- 121 historical awards in this buyer and category group
- +15 points
- 8 recorded award transactions
- +10 points
- Latest award action: 2026-09-03
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.